Publications by authors named "Benjamin C Chandler"

Claim this Profile
B
Bcl-xL inhibition radiosensitizes wild-type triple negative breast cancers with low Mcl-1 expression.
Andrea M Pesch, Benjamin C Chandler, Anna R Michmerhuizen, Hannah M Carter, Nicole H Hirsh

Cancer Res Commun· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes.
Andrea M Pesch, Nicole H Hirsh, Anna R Michmerhuizen, Kassidy M Jungles, Kari Wilder-Romans, Benjamin C Chandler

JCI Insight· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term CDK4/6 Inhibition Radiosensitizes Estrogen Receptor-Positive Breast Cancers.
Andrea M Pesch, Nicole H Hirsh, Benjamin C Chandler, Anna R Michmerhuizen, Cassandra L Ritter

Clin Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel role for TTK in homologous recombination: implications for breast cancer radiosensitivity.
Benjamin C Chandler, Corey Speers

Mol Cell Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination.
Benjamin C Chandler, Leah Moubadder, Cassandra L Ritter, Meilan Liu, Meleah Cameron

J Clin Invest· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation.
Anna R Michmerhuizen, Andrea M Pesch, Leah Moubadder, Benjamin C Chandler, Kari Wilder-Romans

Mol Cancer Ther· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis